Rtw Investments as of June 30, 2018
Portfolio Holdings for Rtw Investments
Rtw Investments holds 40 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 20.9 | $290M | 15M | 19.34 | |
| Regenxbio Inc equity us cm (RGNX) | 10.8 | $149M | 2.1M | 71.75 | |
| Ptc Therapeutics I (PTCT) | 9.9 | $137M | 4.1M | 33.73 | |
| Sarepta Therapeutics (SRPT) | 9.3 | $129M | 979k | 132.18 | |
| Arrowhead Pharmaceuticals (ARWR) | 8.1 | $113M | 8.3M | 13.60 | |
| Dicerna Pharmaceuticals | 4.5 | $62M | 5.0M | 12.25 | |
| Bristol Myers Squibb (BMY) | 3.6 | $50M | 904k | 55.34 | |
| Livanova Plc Ord (LIVN) | 3.1 | $43M | 431k | 99.82 | |
| La Jolla Pharmaceuticl Com Par | 2.8 | $39M | 1.3M | 29.17 | |
| Achillion Pharmaceuticals | 2.8 | $38M | 14M | 2.83 | |
| Arbutus Biopharma (ABUS) | 2.7 | $38M | 5.2M | 7.30 | |
| Alnylam Pharmaceuticals (ALNY) | 2.5 | $35M | 352k | 98.49 | |
| Masimo Corporation (MASI) | 1.8 | $24M | 250k | 97.65 | |
| Solid Biosciences | 1.6 | $23M | 676k | 33.67 | |
| Vericel (VCEL) | 1.6 | $22M | 2.2M | 9.70 | |
| Agenus | 1.5 | $21M | 9.4M | 2.27 | |
| Qiagen Nv | 1.4 | $19M | 529k | 36.16 | |
| Uniqure Nv (QURE) | 1.1 | $16M | 409k | 37.80 | |
| Corium Intl | 1.1 | $15M | 1.9M | 8.01 | |
| Illumina (ILMN) | 1.0 | $14M | 50k | 279.29 | |
| Myokardia | 0.9 | $13M | 261k | 49.65 | |
| Viewray (VRAYQ) | 0.7 | $10M | 1.5M | 6.92 | |
| Polarityte | 0.7 | $10M | 427k | 23.54 | |
| Caredx (CDNA) | 0.7 | $9.4M | 765k | 12.24 | |
| Bovie Medical Corporation | 0.7 | $9.1M | 2.1M | 4.35 | |
| Electrocore | 0.6 | $8.3M | 505k | 16.51 | |
| Nuvectra | 0.6 | $7.9M | 383k | 20.53 | |
| Viveve Med | 0.6 | $7.8M | 2.9M | 2.72 | |
| Odonate Therapeutics Ord | 0.4 | $6.1M | 276k | 22.08 | |
| Neuronetics (STIM) | 0.4 | $5.1M | 190k | 26.61 | |
| Homology Medicines | 0.3 | $4.6M | 226k | 20.40 | |
| Novavax | 0.3 | $3.5M | 2.6M | 1.34 | |
| Vivus Inc conv | 0.2 | $3.1M | 4.0M | 0.78 | |
| Proteostasis Therapeutics In | 0.2 | $3.0M | 1.1M | 2.79 | |
| Novus Therapeutics | 0.1 | $2.1M | 302k | 7.00 | |
| Argenx Se (ARGX) | 0.1 | $2.1M | 26k | 82.87 | |
| Tapimmune | 0.1 | $1.9M | 200k | 9.43 | |
| Bellicum Pharma | 0.1 | $1.1M | 150k | 7.38 | |
| Adverum Biotechnologies | 0.1 | $935k | 176k | 5.30 | |
| Motus Gi Hldgs Incorporated | 0.0 | $428k | 60k | 7.20 |
